Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

Background: During the first wave of COVID-19, hydroxychloroquine (HCQ) was used off-
label despite the absence of evidence documenting its clinical benefits. Since then, a meta …

Background & aims A potential protection against COVID-19 by a high-quality dietary pattern
is to be expected given the biological plausibility supporting the beneficial effects of an …

Abstract In 2020, Coronavirus disease (COVID-19), a new viral respiratory disease caused
by a virus that belongs to Coronaviridae family, has been identified. It is a very severe flu that …

We conducted a prospective population-based cohort study to assess risk factors for
infection, hospitalization, and death from SARS-CoV-2. The study comprised the people …

Objective Mass gathering events (MGEs) are associated with the transmission of COVID-19.
Between 6 and 10 March 2020, several MGEs related to the Falles festival took place in …

New SARS-CoV-2 may pose problems in controlling the COVID-19 pandemic for public
health. We aimed to assess and compare the symptoms and severity of cases due to the …

SARS-CoV-2 infection causes COVID-19, ranging from mild to critical disease in
symptomatic subjects. It is essential to better understand the immunologic responses …

The COVID-19 pandemic is a major threat to the health and well-being of people around the
world that has impacted freedom of movement, social interaction and the economy. The aim …

Background Although the positive effects of good clinical quality standards in perinatal care
and breastfeeding support for women, newborns and families have been already …